Selective loss of resistant alleles at p15INK4B and p16INK4A genes in chemically-induced rat tongue cancers

Oral Oncology

Volumn 42, Issue 7, 2006, Pages 710-717

  Ogawa, Kotaro ^a   Tanuma, Jun ichi ^a   Hirano, Masato ^a   Hirayama, Yoshikazu ^a   Semba, Ichiro ^a   Shisa, Hayase ^b   Kitano, Motoo ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

4 Nitroquinoline 1 oxide induced tongue cancer; Dark Agouti rat; LOH; QTL; Wistar Furth rat

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN; PROTEIN P16INK4A; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 5; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; INCIDENCE; MALE; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; RAT; TONGUE CANCER; TUMOR SUPPRESSOR GENE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CARCINOGENS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; PHENOTYPE; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; RNA, NEOPLASM; TONGUE NEOPLASMS;

EID: 33746224294     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.11.011     Document Type: Article

References (39)

1. Ah-See K.W., Cooke T.G., Pickfor I.R., et al. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54 (1994) 1617-1621
2. Field J.K., Kiaris H., Risk J.M., et al. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 72 (1995) 1180-1188
3. Nunn J., Scholes A.G.M., Liloglou T., et al. Fractional allele loss indicates distinct genetic populations in the development squamous cell carcinoma of the head and neck (SCCHN). Carcinogenesis 20 (1999) 2219-2228
4. Kitano M., Hatano H., and Shisa H. Strain difference of susceptibility to 4-nitroquinoline 1-oxide-induced tongue carcinoma in rats. Jpn J Cancer Res 83 (1992) 843-850
5. Kitano M., Hirayama Y., Tanuma J., et al. Genetic controls of susceptibility and resistance to 4-nitroquinoline 1-oxide-induced tongue carcinomas in rats. Jpn J Cancer Res 87 (1996) 1097-1101
6. Tanuma J., Shisa H., Hiai H., et al. Quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in the rat. Cancer Res 58 (1998) 1660-1664
7. Tanuma J., Kitano M., Shisa H., and Hiai H. Polygenetic susceptibility and resistance to 4-nitroquinoline 1-oxide-induced tongue carcinomas in the rat. J Exp Anim Sci 41 (2000) 68-77
8. Tanuma J., Fujii K., Hirano M., et al. Five quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue cancer in the rat. Jpn J Cancer Res 92 (2001) 610-616
9. INK4A gene in oral squamous cell carcinomas. Cancer Lett 163 (2001) 221-228
10. Mori T., Miura K., Aoki T., Nishihira T., Mori S., and Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54 (1994) 3396-3397
11. Yeudall W.A., Crawford R.Y., Ensley J.F., and Robbins K.C. MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15 (1994) 2683-2686
12. Saxena A., Robertson J.T., and Ali I.U. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas. Oncogene 13 (1996) 661-664
13. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56 (1996) 3630-3633
14. Festing M., and Staats J. Standardized nomenclature for inbred strains of rats. Transplantation 16 (1973) 225
15. Jacob H., Brown D.M., Bunker R.K., et al. A genetic linkage map of the laboratory rat Rattus norvegicus. Nature Genet 9 (1995) 63-69
16. Watanabe T.K., Bihoreau M.T., MaCarthy L.C., et al. A radiation hybrid map of the rat genome containing 5255 markers. Nature Genet 22 (1999) 27-36
17. Tanuma J., Hiai H., Shisa H., et al. Carcinogenesis modifier loci in rat tongue are subject to frequent loss of heterozygosity. Int J Cancer 102 (2002) 638-642
18. Zhou J.N., Hashemi J., Helou K., et al. Analysis of mechanisms and frequency of CDKN2A/B gene loss during progression of RAS-transformed rat embryo fibroblast clones. Somat Cell Mol Genet 24 (1998) 327-339
19. Yamada Y., Matsushiro H., Ogawa M.S., et al. Genetic predisposition to pre-B lymphomas in SL/Kh strain mice. Cancer Res 54 (1994) 403-407
20. Gawkwell L., Bell S.M., Lewis F.A., et al. Rapid detection of allele loss in colorectal tumors using microsatellites and fluorescent DNA technology. Br J Cancer 67 (1993) 1262-1267
21. Canzian F., Salovaara R., Hemminki A., et al. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 56 (1996) 3331-3337
22. Toyokuni S., Okada K., Kondo S., et al. Development of high-grade renal cell carcinomas in the rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Jpn J Cancer Res 89 (1998) 814-820
23. Herman J.G., Graff J.R., Myohanen S., Nelkin, and Baylin S.B. Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 (1998) 9821-9826
24. Swafford D.S., Meddleton S.K., Palmisano W.A., et al. Frequent aberrant methylation of p16INK4A in primary rat lung tumors. Mol Cell Biol 17 (1997) 1366-1374
25. Abe M., Okochi E., Kuramoto T., et al. Cloning of the 5′ upstream region of the rat p16 gene and its role in the silencing. Jpn J Cancer Res 93 (2002) 1100-1106
26. Hirano M, Tanuma J, Hirayama Y, et al. A speed congenic rat strain bearing the tongue cancer susceptibility locus Tscc1 from Dark-Agouti rats. Cancer lett [in press].
27. Cavenee W.K., Koufos A., and Hasen M.F. Recessive mutant gene predisposing to human cancer. Mutat Res 168 (1986) 3-14
28. Stark G.R. Regulation and mechanisms of gene amplification. Proc Am Assoc Cancer Res 34 (1993) 576-577
29. Hartwell L.H., and Kastan M.B. Cell cycle control and cancer. Science 266 (1994) 1821-1828
30. Morgan D.O. Principles of CDK regulation. Nature 374 (1995) 131-133
31. Herman J.G., Merlo A., Mao L., et al. Inactivation of the CDK2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancer. Cancer Res 55 (1995) 4525-4530
32. Merlo A., Herman J.G., Mao L., et al. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1 (1995) 682-692
33. Gonzalez-Zulueta M., Bender C.M., Yang A.S., et al. Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55 (1995) 4531-4535
34. INK4B. Cancer Res 56 (1996) 722-727
35. INK4A characterize the major types of homotological malignancies. Cancer Res 57 (1997) 837-841
36. Nakahara Y., Shintani S., Mihara M., Matsumura T., and Hamakawa H. High frequency methylation of p16INK4A gene during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Oncol Rep 12 (2004) 101-106
37. Belinsky S.A., Nikula K.J., Palmisano W.A., Michels R., Saccomanno G., Gabrielson E., et al. Proc Natl Acad Sci USA 95 (1998) 11891-11896
38. McBride T.J., Preston B.D., and Loeb L.A. Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry 30 (1991) 207-213
39. Partridge M., Emilion G., Falworth M., et al. Patient-specific mutation databases for oral cancer. Int J Cancer 84 (1999) 284-292